Level Bio AB (publ) (NGM:LEVBIO)
Sweden · Delayed Price · Currency is SEK 0.2660
-0.0020 (-0.75%)
At close: Jul 18, 2025
Level Bio AB Company Description
Level Bio AB (publ) manufactures and distributes cutting-edge solutions in the Nordic region and internationally.
It also develops and manufactures diagnostic kits for the clinical market, as well as act as a distributor and full service partner to molecular biology labs in the Nordics.
The company was formerly known as AlphaHelix Molecular Diagnostics AB (publ) and changed its name to Level Bio AB (publ) in May 2024.
Level Bio AB (publ) was incorporated in 1998 and is headquartered in Stockholm, Sweden.
Level Bio AB (publ)
| Country | Sweden |
| Founded | 1998 |
| Industry | In Vitro and In Vivo Diagnostic Substances |
| Employees | 11 |
| CEO | Joakim Granemo |
Contact Details
Address: Västra Finnbodavägen 4B Stockholm, 131 30 Sweden | |
| Phone | 46 86 26 76 00 |
| Website | levelbio.se |
Stock Details
| Ticker Symbol | LEVBIO |
| Exchange | Nordic Growth Market |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Joakim Granemo | Chief Executive Officer |
| Ulrica Karlsson | Chief Financial Officer |